Aligos Therapeutics Inc
NASDAQ:ALGS

Watchlist Manager
Aligos Therapeutics Inc Logo
Aligos Therapeutics Inc
NASDAQ:ALGS
Watchlist
Price: 19.46 USD -0.61% Market Closed
Market Cap: 120m USD
Have any thoughts about
Aligos Therapeutics Inc?
Write Note

Aligos Therapeutics Inc
PP&E Gross

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Aligos Therapeutics Inc
PP&E Gross Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive PP&E Gross Analysis
Latest Figures & CAGR of Competitors

Company PP&E Gross CAGR 3Y CAGR 5Y CAGR 10Y
Aligos Therapeutics Inc
NASDAQ:ALGS
PP&E Gross
$9.8m
CAGR 3-Years
-13%
CAGR 5-Years
-8%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
PP&E Gross
$5.1B
CAGR 3-Years
0%
CAGR 5-Years
10%
CAGR 10-Years
8%
Gilead Sciences Inc
NASDAQ:GILD
PP&E Gross
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Amgen Inc
NASDAQ:AMGN
PP&E Gross
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
PP&E Gross
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
PP&E Gross
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Aligos Therapeutics Inc's PP&E Gross?
PP&E Gross
9.8m USD

Based on the financial report for Dec 31, 2023, Aligos Therapeutics Inc's PP&E Gross amounts to 9.8m USD.

What is Aligos Therapeutics Inc's PP&E Gross growth rate?
PP&E Gross CAGR 5Y
-8%

Over the last year, the PP&E Gross growth was -21%. The average annual PP&E Gross growth rates for Aligos Therapeutics Inc have been -13% over the past three years , -8% over the past five years .

Back to Top